Literature DB >> 26770436

Long term prognosis of acute coronary syndrome with chronic renal dysfunction treated in different therapy units at department of cardiology: a retrospective cohort study.

Cong Fu1, Zulong Sheng1, Yuyu Yao1, Xin Wang1, Chaojun Yu2, Genshan Ma1.   

Abstract

Coronary care unit is common in hospitals and clinical centers which offer intensive care and therapy for severe coronary artery disease patients. However, if coronary care unit could improve the long term prognosis of acute coronary syndrome patients with renal dysfunction remain unknown. Accordingly, we designed this study to evaluate the differences of incidence of major adverse cardiovascular events for acute coronary syndromes patients with renal dysfunction who treated in coronary care unit or normal unit. The primary end point was all cause mortality. A total of 414 acute coronary syndromes patients with renal dysfunction involved in the study. The results showed that during 12-48 months follow-up, death of any cause occurred in 1.8% patients (4 of 247) in coronary care unit group, as compared with 1.8% in the normal group (3 of 167) (hazard ratio, 1.098; 95% confidence interval, 0.246 to 4.904; P=0.903). Kaplan-Meier survival analysis showed that there were no significant differences between the two groups with respect to the risk of death (P=0.903), revascularization (P=0.948), stroke (P=0.542), heart failure (P=0.198). This trial firstly revealed that acute coronary syndromes patients with renal dysfunction treated in coronary care unit and normal units. Our study showed that acute coronary syndromes patients with renal dysfunction treated in coronary care unit obtained no significant benefits compared with patients in normal units, although there was a declining tendency of the risk of major adverse cardiovascular effectswith patients in coronary care unit.

Entities:  

Keywords:  Acute coronary syndrome; chronic renal dysfunction; coronary care units; outcomes

Year:  2015        PMID: 26770436      PMCID: PMC4694336     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

1.  Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention.

Authors:  Yuichiro Kitai; Neiko Ozasa; Takeshi Morimoto; Bingyuan Bao; Yutaka Furukawa; Yoshihisa Nakagawa; Kazushige Kadota; Motoko Yanagita; Satoshi Shizuta; Takeshi Kimura
Journal:  Int J Cardiol       Date:  2013-08-16       Impact factor: 4.164

2.  Less use of standard guideline-based treatment of myocardial infarction in patients with chronic kidney disease: a Danish nation-wide cohort study.

Authors:  Thalia Marie Blicher; Kristine Hommel; Jonas Bjerring Olesen; Christian Torp-Pedersen; Mette Madsen; Anne-Lise Kamper
Journal:  Eur Heart J       Date:  2013-06-24       Impact factor: 29.983

3.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

Authors:  Ph Gabriel Steg; Stefan K James; Dan Atar; Luigi P Badano; Carina Blömstrom-Lundqvist; Michael A Borger; Carlo Di Mario; Kenneth Dickstein; Gregory Ducrocq; Francisco Fernandez-Aviles; Anthony H Gershlick; Pantaleo Giannuzzi; Sigrun Halvorsen; Kurt Huber; Peter Juni; Adnan Kastrati; Juhani Knuuti; Mattie J Lenzen; Kenneth W Mahaffey; Marco Valgimigli; Arnoud van 't Hof; Petr Widimsky; Doron Zahger
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

4.  Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population.

Authors:  Martin J Holzmann; Are Aastveit; Niklas Hammar; Ingmar Jungner; Göran Walldius; Ingar Holme
Journal:  Ann Med       Date:  2011-05-25       Impact factor: 4.709

5.  Cystatin C concentration as a risk factor for heart failure in older adults.

Authors:  Mark J Sarnak; Ronit Katz; Catherine O Stehman-Breen; Linda F Fried; Nancy Swords Jenny; Bruce M Psaty; Anne B Newman; David Siscovick; Michael G Shlipak
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

6.  Impact of estimated glomerular filtration rate on vascular disease extent and adverse cardiovascular events in patients without chronic kidney disease.

Authors:  Yaron Arbel; Amir Halkin; Ariel Finkelstein; Miri Revivo; Shlomo Berliner; Itzhak Herz; Gad Keren; Shmuel Banai
Journal:  Can J Cardiol       Date:  2013-01-11       Impact factor: 5.223

7.  Renal dysfunction and long-term risk of ischemic and hemorrhagic stroke following coronary artery bypass grafting.

Authors:  Martin J Holzmann; Erik Ahlbäck; Anders Jeppsson; Ulrik Sartipy
Journal:  Int J Cardiol       Date:  2012-12-04       Impact factor: 4.164

8.  Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study.

Authors:  Michiel J Bos; Peter J Koudstaal; Albert Hofman; Monique M B Breteler
Journal:  Stroke       Date:  2007-10-25       Impact factor: 7.914

9.  Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal function.

Authors:  Philip Chang; Elise Saddleton; Anne E Laumann; Brenda Schmitz; Dennis P West; Steven M Belknap; Sudharshan Parthasarathy; Beatrice J Edwards; June M McKoy; Frank H Miller
Journal:  Acad Radiol       Date:  2012-07-24       Impact factor: 3.173

10.  The usefulness of rapid point-of-care creatinine testing for the prevention of contrast-induced nephropathy in the emergency department.

Authors:  Je Sung You; Yong Eun Chung; Jong Woo Park; Woonhyoung Lee; Hye-Jeong Lee; Tae Nyoung Chung; Sung Phil Chung; Incheol Park; Seungho Kim
Journal:  Emerg Med J       Date:  2012-07-25       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.